An introduction and overview of the Critical Path Institute and University of Arizona collaboration and the regulatory science graduate program and courses. Plus, a deep dive into precision medicine as a disruptive force across all aspects of the health care system. Specifically, how the development of precision medicine based-therapies continue to pose challenges related to scientific discovery, diagnostic regulatory policy, investment incentives, coverage and reimbursement, and the implementation of new technologies into clinical practice.
Presenters: John-Michael Sauer, PhD, C-Path Biomarker Program Officer and Executive Director of the Predictive Safety Testing Consortium
Tara Sklar, JD, MPH, Professor of Health Law, Director, Health Law & Policy Program
Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020
